news image

January 13, 2023

By Gary A. Puckrein, PhD

WASHINGTON, D.C. (January 13, 2023) — National Minority Quality Forum (NMQF), a nonprofit research and advocacy organization dedicated to ensuring high-risk racial and ethnic populations receive optimal healthcare, announced its collaboration with the U.S. Food and Drug Administration (FDA) on a research study. This study aims to examine and address the issue of distrust among minoritized populations, especially parents of color on social media regarding pediatric COVID-19 vaccines and vaccine boosters. The NMQF and FDA are committed to promoting vaccine confidence and equity in vaccine distribution, especially among historically underserved communities.

As the COVID-19 pandemic continues to impact communities across the nation, it is essential to ensure accurate information reaches all individuals, particularly minoritized populations who have historically faced disparities in healthcare access and outcomes. Social media has become a powerful platform for disseminating information, but it also presents challenges with the spread of misinformation and mistrust.


NMQF and its survey research partner Morning Consult will conduct a voluntary national public opinion online survey of 2,000 US adults from racial and ethnic minorities and underserved populations.


The collaborative research study will focus on understanding the specific concerns, perceptions, and sources of distrust among minoritized populations related to pediatric COVID-19 vaccines and vaccine boosters. By analyzing social media platforms and engaging with diverse communities, the study aims to identify common themes, misconceptions, and barriers that contribute to vaccine hesitancy. The findings will inform targeted strategies and interventions to address these concerns and improve vaccine confidence among minority populations.


Dr. Gary A. Puckrein, President and CEO of the National Minority Quality Forum, expressed enthusiasm about the collaboration, stating, “We are honored to work alongside the FDA on this critical research study. By examining the concerns expressed on social media platforms, we can better understand the reasons behind vaccine hesitancy among minority populations. This collaboration aligns with our mission to eliminate health disparities and ensure equitable access to quality healthcare.”


For more information,  please email NMQF Vice President of Communications & Public Affairs Adjoa Kyerematen at